Delivery Order SPE2DB22D2006-SPE2DB25FW2SZ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $12,877.73 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The award represents a child delivery order issued under a larger contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,578.75 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency awarded a delivery order valued at $14,267.84 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $2,961.21 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,489.84 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order was executed on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,721.08 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,369.90 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 23, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,313.76 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was awarded competitively and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,715.58 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets in a 90-count quantity. The contract was awarded on April 28, 2025, with an ultimate completion date of April 29, 2025, using firm fixed-price pricing with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2SZDelivery Order
The Defense Logistics Agency (DLA) awarded a $35,713.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-set-aside, competitively awarded contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.999 billion and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp supplies critical medications and medical commodities to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. Jardiance, a diabetes medication, represents one of many pharmaceutical products the company delivers through its extensive portfolio of federal contracts with DLA. The company's federal contract awards consistently demonstrate its capability to fulfill competitive procurement requirements across multiple therapeutic domains, with delivery orders structured under firm fixed-price arrangements to ensure cost certainty for federal medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.7k | 7/23/25 |